Fri, May 30, 2025
[Archive]
Volume 10, Issue 2 (May 2025)
JNFS 2025, 10(2): 227-235 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Amini N, Gholami M, Seyyedashour S, Shoae M. Effect of Eight Weeks of Lycopene Supplementation on Oxidative Stress and Adiponectin Gene Expression in Rats with Fatty Liver Disease. JNFS 2025; 10 (2) :227-235
URL: http://jnfs.ssu.ac.ir/article-1-1121-en.html
URL: http://jnfs.ssu.ac.ir/article-1-1121-en.html
Department of Physical Education and Sport Sciences, Faculty of Literature, Humanities and Social Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
Abstract: (612 Views)
| Background: Increased consumption of fat and sugar has been linked to obesity and diseases like non-alcoholic fatty liver disease (NAFLD). Lycopene (LYC), an antioxidant, has been studied for its potential in protecting against fatty liver damage. This study aims to investigate how lycopene affects the antioxidant system and the expression of the adiponectin gene in rats with fatty liver disease. Methods: Wistar rats were divided into three groups: control, n=8), high fat diet (HFD, n=8), and lycopene (HFD+LYC, n=8). The lycopene group received a solution containing 100 mg/kg of lycopene three days a week, while the other groups received standard food for eight weeks via gavage. The levels of adiponectin gene expression in the liver were assessed using the real time PCR method. Additionally, the levels of antioxidant enzymes in the serum were measured using ELISA. Results: Although lycopene did not have a significant therapeutic effect on malondialdehyde (MDA) compared HFD group (P=0.6103), it improved the levels of the SOD enzyme and the expression of the adiponectin gene compared with HFD group (P=0.0002, P=0.0001). This was a significant decrease in collagen deposition in liver tissue of HFD+LYC group compared to HFD group (P<0.0001). Conclusion: Lycopene demonstrates the potential as a therapeutic option for NAFLD. However, more trials are needed to support this idea. |
Keywords: SOD, MDA, Lycopene, Liver, Antioxidant, Adiponectin, Non-alcoholic fatty liver disease, Oxidative stress.
Type of article: orginal article |
Subject:
public specific
Received: 2024/09/7 | Published: 2025/05/30 | ePublished: 2025/05/30
Received: 2024/09/7 | Published: 2025/05/30 | ePublished: 2025/05/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
